SAB BIOTHERAPEUTICS, INC. (SABS) Operating cash flow 2020–2025
SAB BIOTHERAPEUTICS, INC. (SABS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$44.8MFY2025 · since FY2020: $10.0M → -$44.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$44.8M | -30.6% |
| FY2024 | -$34.3M | -36.5% |
| FY2023 | -$25.1M | -7.1% |
| FY2022 | -$23.5M | -1280.7% |
| FY2021 | $2.0M | -80.1% |
| FY2020 | $10.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice